Ignite Creation Date:
2024-05-06 @ 6:56 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05835973
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-04-19
Brief Title:
Evaluation of Sleep Changes in Inflammatory Bowel Diseases IBD Patients
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Evaluation of Sleep Changes As Early Markers of Relapse in Patients with Inflammatory Bowel Diseases IBD
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RECIDREAM
Brief Summary:
Inflammatory Bowel Diseases IBD go through two phases flare and remission Prediction of flares and identification of patients in remission but at high risk of flare are a major issue when taking care of IBD patients
Considering close interactions between sleep immunity and intestinal inflammation sleep disorders could be a predictor of flares
The purpose of this study is to demonstrate that sleep efficacy decreases before IBD flare
Patients in remission will be assessed for IBD symptoms activity scores biological factors and sleep disorders actigraphy DREEM questionnaires during one year
Considering close interactions between sleep immunity and intestinal inflammation sleep disorders could be a predictor of flares
The purpose of this study is to demonstrate that sleep efficacy decreases before IBD flare
Patients in remission will be assessed for IBD symptoms activity scores biological factors and sleep disorders actigraphy DREEM questionnaires during one year
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None